3 'Strong Buy' Biotechs With Impending Catalysts

Edward Lance lorilla,   What's the original strategy of RagingBull's most profitable trader?   Biotech catalysts.   Traders can spend years studying market technicals… but in terms of raw profit potential, Kyle Dennis has found catalyst trading more valuable.   They transitioned him from a broke college graduate… to experiencing an 18,000% ROI in just 4 years.*   And for the most part, it didn't even require playing options.   Because hardly anything causes the price of a stock to move up or down quite like biotech catalysts…   Like a few of these big 2020 winners...   Novavax (NVAX)— 2,672.36% YTD Vaxart (VXRT)— 1,757.14% YTD Trillium Therapeutics (TRIL)— 1,324.27% YTD Genprex (GNPX)— 1,081.25% YTD   Now, there's a whole range of catalysts that could cause biotechs to move like that.   And it's not just the intense race for a coronavirus vaccine that can send them way up (or down)...   Earnings releases, company news, analyst comments, lawsuits…   Or a couple of Kyle's personal favorites— FDA approvals and the commencement of Phase I, II, or III trials.   See, what Kyle will do is trade the stock in anticipation of the event…   And if a stock has a positive catalyst, it will go up.   Like Spectrum Pharmaceuticals (SPPI).   Kyle bought 10k SPPI at $4.31 this past Tuesday and on Friday it had a press release about some encouraging data...     Kyle locked in profits at $4.75 for about $4,400.   But there's more where that came from.   What ideas is Kyle currently looking at for potential runs over the coming week?     Tonix Pharmaceuticals (TNXP):   Catalyst Dates: Phase 3 Data due Q3 3020, can come out any day.   Buy zone: $0.85 to $1 Profit zone: $1.5+ Stop zone: $0.8 or below No options         Brainstorm Cell Therapeutics (BCLI):   Catalyst Dates: Phase 3 top line data Due by November 2020.   Buy zone: $14 - $15 Profit zone: $19+ Stop zone: $13.2 or below   Options: November premiums are sky high, no trade for me         Vaccinex (VCNX):   Catalyst Dates: Phase 2 top line data Due in October 2020.   Buy zone: $5.4 - $5.8 Profit zone: Sell partial at $7, ride the rest Stop zone: $4.7 or below   Options: illiquid, be very careful getting involved         Want to learn the strategies that Kyle is using to trade biotechs with catalysts like these?   Check out Kyle's upcoming catalyst training workshop here.     Hurry, your window of opportunity ends soon.   Receive JC's Daily, Weekly, And Monthly Trading Insights That Cost Hedge Funds $10K Per Day His Next "Daily's" Watchlist Drops on Monday Grab It Here     How To Play TSLA's Battery Day By Jason Bond of Weekly Windfalls 3 Small Account Options Strategies You Can Try Today By Jeff Bishop of Total Alpha My Approach To The Markets By JC Parets of Chart Hunter Don't Miss This Hot Stock That's Tearing Up The Dark Pools By Ben Sturgill of Daily Profit Machine Top 3 Barriers To Angel Investing By Chris Graebe of Angel Insights Swing Trade Like a Pro By Nathan Bear of Weekly Money Multiplier AMA: Help! I'm Having Trouble Growing My Account… By Kyle Dennis of Biotech Breakouts RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 Click Here to stop receiving emails from support@ragingbull.com Unsubscribe from all RagingBull emails DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website,application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication.